# World Health Organization (WHO) , COVID19 Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt

> **NCT06267326** · PHASE1,PHASE2 · COMPLETED · sponsor: **Nasser Institute For Research and Treatment** · enrollment: 35 (actual)

## Conditions studied

- Mucormycosis; Rhinocerebral (Etiology)
- COVID-19

## Interventions

- **PROCEDURE:** debridment

## Key facts

- **NCT ID:** NCT06267326
- **Lead sponsor:** Nasser Institute For Research and Treatment
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-23
- **Primary completion:** 2022-06-12
- **Final completion:** 2023-08-21
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06267326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06267326, "World Health Organization (WHO) , COVID19 Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06267326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*